The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...

People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...

By screening people for eating disorders and disordered eating before these medications are prescribed, we can prevent ...

PatchMD, a leading innovator in transdermal nutrient delivery, is excited to announce the launch of its new GLP-1 Support ...

SAN DIEGO -- Two retrospective studies hinted at potential negative effects of GLP-1 receptor agonists for patients requiring ...

Tirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...

As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health ...

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 – glucagon-like peptide-1 receptor agonists – drugs, including semaglutide and tirzepatide, as an ...

Several weight loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 ...